Press Releases

Date	Title	Company
08-Dec-2022	SK pharmteco announces new standalone Analytical Services from its SK biotek Ireland Swords Campus	SK pharmteco
08-Dec-2022	Laevoroc Oncology Announces Publication Identifying Purine Nucleoside Phosphorylase (PNP) as a Novel Metabolic Immune Checkpoint	Laevoroc Oncology
08-Dec-2022	The Lancet Publishes Results from Two Bimekizumab Phase 3 Studies in Psoriatic Arthritis	UCB
08-Dec-2022	MetrioPharm Announces Topline Data of its Phase IIa Study of MP1032 in COVID-19 Patients	MetrioPharm AG
08-Dec-2022	Neuraxpharm expands into the Netherlands	Neuraxpharm
08-Dec-2022	Anjarium Biosciences appoints ex-Novartis gene therapy leader Otmane Boussif, DSc as Chief Technology Officer	Anjarium Biosciences
08-Dec-2022	BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis	Sciad Newswire
08-Dec-2022	Relief Therapeutics Announces Executive Leadership Team Changes	Relief Therapeutics Holding SA
08-Dec-2022	Biotest AG: First patient enrolled in phase II clinical trial for treatment of chronic hepatitis B with hyperimmunoglobulins	Biotest AG
08-Dec-2022	Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Daktronics, Inc. (DAKT) on Behalf of Investors	Businesswire
08-Dec-2022	Shareholder Alert: Robbins LLP Informs Investors of Class Action Against NeoGenomics, Inc. (NEO)	Businesswire
08-Dec-2022	Puma Biotechnology Presents Updated Findings from the TBCRC-022 Trial at the 2022 San Antonio Breast Cancer Symposium	Businesswire
08-Dec-2022	Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	Businesswire
07-Dec-2022	TriMas Packaging Facility Achieves FSSC 22000, a Leading Food Safety Production Certification	Businesswire
07-Dec-2022	New Hand Therapy app from Chelsea and Westminster Hospital NHS Foundation Trust improves patient experience	CW+
07-Dec-2022	SpineThera Announces Results for SX600 from its SALIENT Phase 2 Sciatica Pain Clinical Trial Supporting the Potential for Best-In-Class Therapy	Businesswire
07-Dec-2022	Hyfe Listed on 2022 CB Insights Digital Health 150 List Recognizing the Most Promising Digital Health Companies	Businesswire
07-Dec-2022	INVESTOR ALERT: NeoGenomics, Inc. Investors with Substantial Losses Have Opportunity to Lead the NeoGenomics Class Action Lawsuit - NEO	Businesswire
07-Dec-2022	Tevogen Bio to Study its Investigational COVID-19 T Cell Therapy in Immunocompromised Patients Who are Unable to Benefit From Currently Available Prevention or Treatment Options	Businesswire
07-Dec-2022	2022 World Market for Vaccines: The Market is Valued at $202.6 Billion up from $34.1 Billion in 2017 - ResearchAndMarkets.com	Businesswire